{"id":"W4211167150","doi":"10.1007/s40257-018-0353-x","title":"Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)","year":2018,"lang":"en","type":"erratum","venue":"American Journal of Clinical Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Etanercept; Plaque psoriasis; Psoriasis; Clinical trial; Randomized controlled trial; Internal medicine; Dermatology; Pharmacology; Psoriatic arthritis; Tumor necrosis factor alpha; Secukinumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01585041,0.0007398665,0.01391801,0.001681122,0.0001121378,0.00004152285,0.0005601415,0.001198543,0.0001763031],"category_scores_gemma":[0.02936502,0.0005907858,0.00143016,0.0009272443,0.0008028668,0.0001483497,0.0002565636,0.00223221,0.00004223312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001122124,"about_ca_system_score_gemma":0.0009750917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001935001,"about_ca_topic_score_gemma":0.002338246,"domain_scores_codex":[0.9673917,0.02078244,0.009904513,0.001078665,0.000192336,0.0006502928],"domain_scores_gemma":[0.9494175,0.04418656,0.005091319,0.0005545316,0.0003547166,0.0003953337],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6240871,0.0009055909,0.003929359,0.00001964855,0.00441646,0.0002608327,0.001816366,0.0001061545,0.0002228196,0.000006091031,0.03544027,0.3287893],"study_design_scores_gemma":[0.9187284,0.009964659,0.02565049,0.00279779,0.008542168,0.001516016,0.002710216,0.0009471715,0.0003917773,0.0003510068,0.02660923,0.001791081],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9712677,0.001588483,0.003954657,0.0019709,0.01957624,0.001300592,0.0001462727,0.00001457241,0.0001805544],"genre_scores_gemma":[0.9899853,0.005464517,0.001339667,0.001250213,0.0009331929,0.00004310179,0.0001600296,0.00006535151,0.0007586482],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3269982,"threshold_uncertainty_score":0.9996544,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04548296740520304,"score_gpt":0.4051798012041642,"score_spread":0.3596968337989612,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}